Watson Pharmaceuticals, Inc. confirmed that it has filed with the FDA an Abbreviated New Drug Application (ANDA) for Drospirenone and Ethinyl Estradiol and Levomefolate Calcium Tablets, 3.0mg/0.02mg/0.451mg and Levomefolate Calcium Tablets, 0.451mg, a generic version of Bayer HealthCare Pharmaceuticals Inc.'s Beyaz.
SIGN IN WITH ONE OF YOUR SOCIAL ACCOUNTS
Sign in with your MPR account
Keep me signed in Forgot your password?
REGISTER FOR FREE WITH ONE OF YOUR SOCIAL ACCOUNTS
REGISTER FOR FREE WITH A MPR ACCOUNT
Enter your MPR registration email address to receive a password reset link.
ENTER NEW PASSWORD